Offer - Urjas Oil for just ₹ 1 X
Ercob is a commercial drug that is prescribed in the form of Drops. Secondary and off-label uses of Ercob have also been mentioned below.
The right dosage of Ercob depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
While these are the most often observed Ercob side effects, there are can be others also. These have been listed below. Usually, these side effects of Ercob go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Ercob is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if Ercob has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ercob related warnings section.
Ercob is not recommended if you suffer from certain medical conditions as it can have adverse effects. Atrial Fibrillation, Heart Failure, Myasthenia Gravis (MG) are examples of such conditions. Other conditions have been mentioned below in the Ercob contraindications section.
Additionally, Ercob may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Ercob is safe while driving, and is is addictive in nature.
Ercob is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Ercob safe for pregnant women?
Ercob is safe for pregnant women.
Is the use of Ercob safe during breastfeeding?
Ercob does not show any harmful effects in lactating women.
What is the effect of Ercob on the Kidneys?
Ercob is completely safe for kidneys.
What is the effect of Ercob on the Liver?
Ercob does not damage the liver.
What is the effect of Ercob on the Heart?
Ercob is completely safe for the heart.
Ercob should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Ercob unless your doctor advises you to do so -
Is this Ercob habit forming or addictive?
Ercob does not cause addiction.
Interaction between Food and Ercob
You can take Ercob with food.
Interaction between Alcohol and Ercob
You may consume alcohol while taking Ercob. But caution is still important.
Yes, Ercob causes constipation. It is a common side effect of this drug. However, if you experience severe constipation after taking this medicine, please consult your doctor immediately and follow his/her instructions.
Discontinuing Ercob on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
Ercob is a prescription drug, hence do not take Ercob without consulting doctor. It can be harmful to patients to take this medicine without a doctor's advice.
No, Ercob is not a painkiller. It is an antibiotic that belongs to the class of medications called fluoroquinolone.
Ercob is a broad-spectrum antibiotic, active against both Gram-positive and Gram-negative bacteria. It works by inhibiting the bacterial cell division and stops the working of enzyme which is responsible for cell division. It is effective against a large number of bacteria, even those bacteria which are resistant to other drugs.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792